Clearmind Medicine Inc

/Clearmind Medicine Inc

IPO

Clearmind Medicine Inc

Pharmaceutical

We are a pre-clinical pharmaceutical company approaching phase 1 clinical trials, that develops novel psychedelic medicines to solve widespread, yet under-served, health problems.

Symbol

CMND

Price Range
$6.00 - $8.00

Final Shares
1,255,000

Anticipated Date
November 15, 2022

Underwriters
AEGIS CAPITAL CORP.

This offering is no longer available

To view the prospectus for Clearmind Medicine Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange